Wilson, Sonsini, Goodrich & Rosati
Methods and compositions involving miRNA and miRNA inhibitor molecules
The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.
ASURAGEN, INC.
A C C A A C A A C C A A A C A C C A C C A C A C C C A C C A A C C C C C C A A A C A
A61K C12N C12N A61K A61P C12N A61P A61P C12N C12N A61P A61P A61P C12Q A61P C12N C12Q A61N C12N C12N A61P C12N A61P C12N C12N C12N A61P C12N C12Q A61P A61K C12Q C12N C12N C12N C12N C12N A61P A61K A61P C12N A61K
inventional additional additional inventional inventional inventional inventional inventional inventional additional inventional inventional inventional additional inventional additional additional inventional additional additional inventional inventional inventional additional additional additional inventional additional inventional inventional inventional inventional additional additional additional additional additional inventional inventional inventional additional inventional
David Angie Rich Kevin Lance Mike Dmitriy Eric
Brown Cheng Jarvis Kelnar Ford Byrom Ovcharenko Devroe